Chronic Rhinosinusitis Market 2020 Size, Share, Research Methodology, Revenue By 2027

April 06 22:04 2021
Adoption of minimally invasive techniques, technological advancements, substantial prevalence of rhinosinusitis with favorable reimbursement scenarios are forecasted to fuel the market growth

The global Chronic Rhinosinusitis Market was valued at USD 2132.5  million in 2019 and is expected to reach USD 3508.0 million by 2027, at a CAGR of 7.4%, According to the current analysis of Emergen Research. Development and manufacture of proficient sinusitis drugs are likely to be highly demanded for efficient treatment of chronic rhinosinusitis as, pollutants, fungal infections and allergies immensely contribute to the rising incidence of rhinosinusitis. Moreover, growing prevalence of growing prevalence of chronic asthma, inflammation of mucosal linings of the nasal passage, and cases of paranasal sinuses are expected to fuel the growth prospects of chronic rhinosinusitis market in the forecast period. 

Request a sample copy of the report @ https://www.emergenresearch.com/request-sample/74

Key Highlights From The Report

  • Xolair (Omalizumab) manufactured by Novartis, was approved in August 2020, by European Commission (EC). The product development is attributed to treat severe chronic rhinosinusitis with nasal polyps
  • Due to considerable employability of antibiotics and their effectiveness in efficiently treating chronic rhinosinusitis, antibiotics product segment held largest market share of 41.6% in 2019 and is likely to dominate the industry during 2019-2027
  • Owing to favourable reimbursement policies, high prevalence of target disease and technological advancements among other encouraging scenarios North America accounted for largest market revenue with significant market share of 37.2% in 2019
  • Key market companies studied and profiled for this research include AstraZeneca, Bayer AG, Ivax Pharmaceuticals, Pfizer, Novartis Pharmaceuticals Corporation, Sanofi, Sunovion Pharmaceuticals, Cipla, Smith & Nephew, Medtronic, SinuSys Corporation, Olympus Corporation and Acclarent among other companies

Emergen Research have segmented Chronic Rhinosinusitis Market on the basis of product, disease type, distribution channel and region:

Product Outlook (Revenue in Million USD; 2017–2027)

  • Steroids
    • Topical Nasal Steroid
    • Systemic Steroids
  • Nasal Irrigation
    • Hypertonic and Isotonic Saline
    • Steroid Nasal Irrigation
    • Topical Antibiotic Therapy
  • Surgical Based
    • Ethmoidectomy
    • Endoscopic Intranasal Intervention
    • Others
  • Antibiotics
    • Amoxicillin-Clavulanate
    • Clindamycin
    • Sulfamethoxazole
    • Levofloxacin
  • Macrolide Therapy
  • Antifungal Therapy

Disease Outlook (Revenue in Million USD; 2017–2027)

  • Anatomical Differences
  • Nasal Tumors
  • Mucosal Edema
  • Non-Allergic Rhinitis
  • Immune Deficiency
  • Other

Distribution Channel (Revenue in Million USD; 2017–2027)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Other

Regional Bifurcation:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/74

Key Factors influencing market remuneration:

  • The global Chronic Rhinosinusitis market report includes a detailed study of the product spectrum of the market and further describes the different product types, including One-sided, Two-sided, and Others.
  • The report zeroes in on the overall market dynamics and presents information with regard to the producers and distributors, manufacturing cost structure, and downstream buyers.
  • Details pertaining to the expected growth rate, industry share, revenue accumulated, and product segmentationare depicted in this report.
  • The application landscape of the global Chronic Rhinosinusitis market can be categorized into For Human, For Animals, and Others.
  • The study further examines the industry share and product demand of each application, coupled withthe predicted growth patterns of the various application segments.
  • Other vital factors, such as market concentration ratioand raw material processing rate, have also been covered under the latest study.

Table of Content

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Chronic Rhinosinusitis Market Segmentation & Impact Analysis
    4.1. Chronic Rhinosinusitis Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Intensifying Prevalence of rhinosinusitis
                    4.2.2.2. Emergence of efficient therapeutics for Chronic rhinosinusitis
                    4.2.2.3. Favorable reimbursements
          4.2.3. Market restraints analysis
                    4.2.3.1. High cost of treatment
                    4.2.3.2. Side effects associated with the treatment/surgery
    4.3. Technological Insights
    4.4. Clinical Pipeline Analysis
    4.5. Regulatory Framework
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Covid-19 Impact Analysis

Chapter 5. Chronic Rhinosinusitis Market By Product Type Insights & Trends, Revenue (USD Million)
    5.1. Product Type Dynamics & Market Share, 2019 & 2027
          5.1.1. Steroids
          5.1.2. Nasel irrigation
          5.1.3. Surgical Based
          5.1.4. Antibiotics
          5.1.5. Macrolide Therapy
          5.1.6. Antifungal Therapy

Chapter 6. Chronic Rhinosinusitis Market By Disease Insights & Trends Revenue (USD Million)
    6.1. Disease Dynamics & Market Share, 2019 & 2027
          6.1.1. Anatomical Differences
          6.1.2. Nasal Tumors
          6.1.3. Mucosal Edema
          6.1.4. Non-Allergic Rhinitis
          6.1.5. Immune Deficiency
          6.1.6. Other

CONTINUED…!!

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

Thank you for reading our report. To know more about the report, please connect with us, and our team will ensure the report is customized to meet your requirements.

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

  Categories:
view more articles

About Article Author